| Application no. and date | 18185835.8 (espacenet) (Federated) (European Patent Register), 20130927 | | Patent/reg. no. and date | DK/EP 3415517, 20220420 | | Publication date | 20181219 | | Priority no. and date | JP 2012217679, 20120928 | | EP pub. no. and date |
EP 3415517 20181219 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome
Chuo-ku
Osaka-shi
Osaka 541-0045, JP | | Applicant ref. no. | V161995DK | | Inventor | MIWA, Kazuhiro, TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85 Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi, Osaka 532-0024, JP,
SASAKI, Tsuyoshi, TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85 Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi, Osaka 532-0024, JP,
KOMURA, Fumiya, TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85 Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi, Osaka 532-0024, JP | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61P 15/08 (2006.01) , A61P 5/02 (2006.01) , C07D 495/04 (2006.01) | | Title | KRYSTALLINSK FORM AF 1-(4-1-(2,6-DIFLUORBENZYL)-5-DIMETHYLAMINOMETHYL-3-(6-
METHOXYPYRIDAZIN-3-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROTHIENO(2,3-D)-PYRIMIDIN-
6YL)PHENYL)-3-METHOXYUREA | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
